Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rahul N Doshi

Showing results (61-70 of 70) with videos related to

Pageof 7
Sort By:
You have reached the last page of results.This site can display upto 70 results.
Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology|June 1, 2026
Percutaneous left atrial appendage closure following catheter ablation therapy of atrial fibrillation: outcomes stratified by bleeding risk - a sub-analysis of the OPTION studyKaren P Phillips, Devi G Nair, Lucas V A Boersma, et al.
Heart Rhythm|March 15, 2025
Dual-chamber leadless pacemaker implant procedural outcomes: Insights from the AVEIR DR i2i studyRahul N Doshi, James E Ip, Pascal Defaye, et al.
Circulation. Arrhythmia and Electrophysiology|September 28, 2023
Retrieval of Chronically Implanted Dual-chamber Leadless Pacemakers in an Ovine ModelRajesh S Banker, Marian K Rippy, Nicole Cooper, et al.
Journal of Cardiovascular Electrophysiology|April 19, 2012
Worldwide experience with the robotic navigation system in catheter ablation of atrial fibrillation: methodology, efficacy and safetyRong Bai, Luigi DI Biase, Miguel Valderrabano, et al.
JAMA|October 27, 2020
Effect of Catheter Ablation With Vein of Marshall Ethanol Infusion vs Catheter Ablation Alone on Persistent Atrial Fibrillation: The VENUS Randomized Clinical TrialMiguel Valderrábano, Leif E Peterson, Vijay Swarup, et al.
Heart Rhythm|January 22, 2021
Determinants of outcome impact of vein of Marshall ethanol infusion when added to catheter ablation of persistent atrial fibrillation: A secondary analysis of the VENUS randomized clinical trialAdi Lador, Leif E Peterson, Vijay Swarup, et al.
Journal of Cardiovascular Electrophysiology|February 17, 2022
A wearable cardioverter defibrillator with a low false alarm rateJeanne E Poole, Marye J Gleva, Ulrika Birgersdotter-Green, et al.
Circulation|May 2, 2007
Inductionless or limited shock testing is possible in most patients with implantable cardioverter- defibrillators/cardiac resynchronization therapy defibrillators: results of the multicenter ASSURE Study (Arrhythmia Single Shock Defibrillation Threshold Testing Versus Upper Limit of Vulnerability: Risk Reduction Evaluation With Implantable Cardioverter-Defibrillator Implantations)John D Day, Rahul N Doshi, Peter Belott, et al.
JACC. Clinical Electrophysiology|November 7, 2025
Atrial Fibrillation Recurrence After Left Atrial Appendage Occlusion in Patients Undergoing Ablation: OPTION Trial Sub-analysisArwa Younis, Devi G Nair, Luigi Di Biase, et al.
Circulation. Arrhythmia and Electrophysiology|November 13, 2025
One-Year Outcomes of the MODULAR ATP Trial: A Novel Leadless Pacemaker in Wireless Communication With a Subcutaneous Implantable Cardioverter DefibrillatorMichael S Lloyd, Vivek Y Reddy, Paul Roberts, et al.
Pageof 7

Showing results (61-70 of 70) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 70 results.
Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology|June 1, 2026
Percutaneous left atrial appendage closure following catheter ablation therapy of atrial fibrillation: outcomes stratified by bleeding risk - a sub-analysis of the OPTION studyKaren P Phillips, Devi G Nair, Lucas V A Boersma, et al.
Heart Rhythm|March 15, 2025
Dual-chamber leadless pacemaker implant procedural outcomes: Insights from the AVEIR DR i2i studyRahul N Doshi, James E Ip, Pascal Defaye, et al.
Circulation. Arrhythmia and Electrophysiology|September 28, 2023
Retrieval of Chronically Implanted Dual-chamber Leadless Pacemakers in an Ovine ModelRajesh S Banker, Marian K Rippy, Nicole Cooper, et al.
Journal of Cardiovascular Electrophysiology|April 19, 2012
Worldwide experience with the robotic navigation system in catheter ablation of atrial fibrillation: methodology, efficacy and safetyRong Bai, Luigi DI Biase, Miguel Valderrabano, et al.
JAMA|October 27, 2020
Effect of Catheter Ablation With Vein of Marshall Ethanol Infusion vs Catheter Ablation Alone on Persistent Atrial Fibrillation: The VENUS Randomized Clinical TrialMiguel Valderrábano, Leif E Peterson, Vijay Swarup, et al.
Heart Rhythm|January 22, 2021
Determinants of outcome impact of vein of Marshall ethanol infusion when added to catheter ablation of persistent atrial fibrillation: A secondary analysis of the VENUS randomized clinical trialAdi Lador, Leif E Peterson, Vijay Swarup, et al.
Journal of Cardiovascular Electrophysiology|February 17, 2022
A wearable cardioverter defibrillator with a low false alarm rateJeanne E Poole, Marye J Gleva, Ulrika Birgersdotter-Green, et al.
Circulation|May 2, 2007
Inductionless or limited shock testing is possible in most patients with implantable cardioverter- defibrillators/cardiac resynchronization therapy defibrillators: results of the multicenter ASSURE Study (Arrhythmia Single Shock Defibrillation Threshold Testing Versus Upper Limit of Vulnerability: Risk Reduction Evaluation With Implantable Cardioverter-Defibrillator Implantations)John D Day, Rahul N Doshi, Peter Belott, et al.
JACC. Clinical Electrophysiology|November 7, 2025
Atrial Fibrillation Recurrence After Left Atrial Appendage Occlusion in Patients Undergoing Ablation: OPTION Trial Sub-analysisArwa Younis, Devi G Nair, Luigi Di Biase, et al.
Circulation. Arrhythmia and Electrophysiology|November 13, 2025
One-Year Outcomes of the MODULAR ATP Trial: A Novel Leadless Pacemaker in Wireless Communication With a Subcutaneous Implantable Cardioverter DefibrillatorMichael S Lloyd, Vivek Y Reddy, Paul Roberts, et al.
Pageof 7